The plasminogen activator system:: biology and regulation

被引:324
作者
Irigoyen, JP
Muñoz-Cánoves, P
Montero, L
Koziczak, M
Nagamine, Y
机构
[1] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
[2] Inst Recerca Oncol, E-08907 Barcelona, Spain
关键词
cell invasion; cell motility; fibrinolysis; metastasis; mRNA stability; plasminogen activator; plasminogen activator inhibitor; signal transduction; transcriptional regulation; uPA receptor;
D O I
10.1007/PL00000615
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The regulation of plasminogen activation involves genes for two plasminogen activators (tissue type and urokinase type), two specific inhibitors (type 1 and type 2), and a membrane-anchored urokinase-type plasminogen-activator-specific receptor. This system plays an important role in various biological processes involving extracellular proteolysis. Recent studies have revealed that the system, through interplay with integrins and the extracellular matrix protein vitronectin, is also involved in the regulation of cell migration and proliferation in a manner independent of proteolytic activity. The genes are expressed in many different cell types and their expression is under the control of diverse extracellular signals. Gene expression resects the levels of the corresponding mRNA, which should be the net result of synthesis and degradation. Thus, modulation of mRNA stability is an important factor in overall regulation. This review summarizes current understanding of the biology and regulation of genes involved in plasminogen activation at different levels.
引用
收藏
页码:104 / 132
页数:29
相关论文
共 416 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor [J].
Allgayer, H ;
Wang, H ;
Wang, Y ;
Heiss, MM ;
Bauer, R ;
Nyormoi, O ;
Boyd, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4702-4714
[3]   INHIBITION OF PROTEIN-SYNTHESIS IN LLC-PK1 CELLS INCREASES CALCITONIN-INDUCED PLASMINOGEN-ACTIVATOR GENE-TRANSCRIPTION AND MESSENGER-RNA STABILITY [J].
ALTUS, MS ;
PEARSON, D ;
HORIUCHI, A ;
NAGAMINE, Y .
BIOCHEMICAL JOURNAL, 1987, 242 (02) :387-392
[4]  
ALTUS MS, 1991, J BIOL CHEM, V266, P21190
[5]   The 3′ to 5′ degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3′ to 5′ exonucleases of the exosome complex [J].
Anderson, JSJ ;
Parker, R .
EMBO JOURNAL, 1998, 17 (05) :1497-1506
[6]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - REACTIVE CENTER AND AMINO-TERMINAL HETEROGENEITY DETERMINED BY PROTEIN AND CDNA SEQUENCING [J].
ANDREASEN, PA ;
RICCIO, A ;
WELINDER, KG ;
DOUGLAS, R ;
SARTORIO, R ;
NIELSEN, LS ;
OPPENHEIMER, C ;
BLASI, F ;
DANO, K .
FEBS LETTERS, 1986, 209 (02) :213-218
[7]   RECEPTOR-MEDIATED ENDOCYTOSIS OF PLASMINOGEN ACTIVATORS AND ACTIVATOR/INHIBITOR COMPLEXES [J].
ANDREASEN, PA ;
SOTTRUPJENSEN, L ;
KJOLLER, L ;
NYKJAER, A ;
MOESTRUP, SK ;
PETERSEN, CM ;
GLIEMANN, J .
FEBS LETTERS, 1994, 338 (03) :239-245
[8]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[9]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[10]  
2-Z